CN104998299B - 一种脱细胞抗钙化心脏补片及其制备方法 - Google Patents
一种脱细胞抗钙化心脏补片及其制备方法 Download PDFInfo
- Publication number
- CN104998299B CN104998299B CN201510454619.4A CN201510454619A CN104998299B CN 104998299 B CN104998299 B CN 104998299B CN 201510454619 A CN201510454619 A CN 201510454619A CN 104998299 B CN104998299 B CN 104998299B
- Authority
- CN
- China
- Prior art keywords
- cell
- anticalcium
- processing
- cardiac patch
- pericardium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000000747 cardiac effect Effects 0.000 title claims abstract description 47
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 64
- 239000011259 mixed solution Substances 0.000 claims abstract description 11
- 239000004094 surface-active agent Substances 0.000 claims abstract description 5
- 210000003516 pericardium Anatomy 0.000 claims description 48
- 241000283690 Bos taurus Species 0.000 claims description 37
- 241000282887 Suidae Species 0.000 claims description 30
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 206010010254 Concussion Diseases 0.000 claims description 19
- 230000009514 concussion Effects 0.000 claims description 19
- 239000008213 purified water Substances 0.000 claims description 19
- 239000005022 packaging material Substances 0.000 claims description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 230000001954 sterilising effect Effects 0.000 claims description 13
- 239000011780 sodium chloride Substances 0.000 claims description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- 230000008859 change Effects 0.000 claims description 9
- 210000001519 tissue Anatomy 0.000 claims description 9
- 239000008280 blood Substances 0.000 claims description 7
- 210000004369 blood Anatomy 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 3
- 238000010894 electron beam technology Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 238000011017 operating method Methods 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 12
- 208000028831 congenital heart disease Diseases 0.000 abstract description 5
- 230000005847 immunogenicity Effects 0.000 abstract description 5
- 238000005238 degreasing Methods 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- 208000002330 Congenital Heart Defects Diseases 0.000 abstract description 3
- 239000003513 alkali Substances 0.000 abstract description 3
- 239000011148 porous material Substances 0.000 abstract description 3
- 208000035478 Interatrial communication Diseases 0.000 abstract description 2
- 208000001910 Ventricular Heart Septal Defects Diseases 0.000 abstract description 2
- 208000013914 atrial heart septal defect Diseases 0.000 abstract description 2
- 206010003664 atrial septal defect Diseases 0.000 abstract description 2
- 201000003130 ventricular septal defect Diseases 0.000 abstract description 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 230000035485 pulse pressure Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 50
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 27
- 208000004434 Calcinosis Diseases 0.000 description 22
- 230000015556 catabolic process Effects 0.000 description 11
- 238000006731 degradation reaction Methods 0.000 description 11
- 230000002308 calcification Effects 0.000 description 10
- 238000002513 implantation Methods 0.000 description 8
- 230000002980 postoperative effect Effects 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 7
- 108010035532 Collagen Proteins 0.000 description 7
- 210000000577 adipose tissue Anatomy 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 229920001436 collagen Polymers 0.000 description 7
- 230000008439 repair process Effects 0.000 description 7
- 210000002837 heart atrium Anatomy 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000007943 implant Substances 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 4
- 235000005288 Annona lutescens Nutrition 0.000 description 3
- 244000030795 Annona lutescens Species 0.000 description 3
- 229920004934 Dacron® Polymers 0.000 description 3
- 230000009172 bursting Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 210000002318 cardia Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000013527 degreasing agent Substances 0.000 description 2
- 238000005237 degreasing agent Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010067268 Post procedural infection Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000003328 fibroblastic effect Effects 0.000 description 1
- 231100000171 higher toxicity Toxicity 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005297 material degradation process Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510454619.4A CN104998299B (zh) | 2015-07-29 | 2015-07-29 | 一种脱细胞抗钙化心脏补片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510454619.4A CN104998299B (zh) | 2015-07-29 | 2015-07-29 | 一种脱细胞抗钙化心脏补片及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104998299A CN104998299A (zh) | 2015-10-28 |
CN104998299B true CN104998299B (zh) | 2018-01-23 |
Family
ID=54371329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510454619.4A Expired - Fee Related CN104998299B (zh) | 2015-07-29 | 2015-07-29 | 一种脱细胞抗钙化心脏补片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104998299B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107029293B (zh) * | 2017-03-03 | 2022-06-21 | 济南金泉生物科技有限公司 | 一种引导骨再生心包胶原膜及其制备方法和用途 |
CN110559485B (zh) * | 2019-09-25 | 2021-02-02 | 北京大清生物技术股份有限公司 | 一种生物组织基质材料及其制备方法与应用 |
CN113425907A (zh) * | 2020-03-23 | 2021-09-24 | 四川大学 | 一种心包膜材料及其制备方法和用途 |
CN113080187B (zh) * | 2021-03-31 | 2022-06-21 | 上海纽脉医疗科技有限公司 | 用于去除磷脂和细胞碎片的组合物及去除生物组织上磷脂和细胞碎片的方法 |
CN114209886B (zh) * | 2021-11-09 | 2022-12-02 | 江苏臻亿医疗科技有限公司 | 一种生物组织材料及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103191466B (zh) * | 2013-04-15 | 2014-07-23 | 潘华倩 | 制备人体或动物脱细胞组织的方法 |
CN103520780B (zh) * | 2013-10-24 | 2015-03-25 | 陕西瑞盛生物科技有限公司 | 一种生物羊膜及其制备方法 |
CN104524634B (zh) * | 2014-12-17 | 2017-01-18 | 陕西佰傲再生医学有限公司 | 一种组织修复材料的制备方法 |
-
2015
- 2015-07-29 CN CN201510454619.4A patent/CN104998299B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN104998299A (zh) | 2015-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104998299B (zh) | 一种脱细胞抗钙化心脏补片及其制备方法 | |
EP3040088B1 (en) | Method for preparing an animal decellularized tissue matrix material and a decellularized tissue matrix material prepared thereby | |
CN101366975B (zh) | 脱细胞小肠粘膜下层生物材料的制备方法 | |
CN104524634B (zh) | 一种组织修复材料的制备方法 | |
US11185611B2 (en) | Method and apparatus for decellularization of tissue | |
US20210030923A1 (en) | Biological valve material, preparation method and use thereof, and cross-linking agent and use thereof | |
CN105935454A (zh) | 一种脱细胞基质源组织工程支架及其制备方法和应用 | |
US20160101215A1 (en) | Preparation method for implantable medical biological materials of animal origin | |
Snyder et al. | Strategies for development of decellularized heart valve scaffolds for tissue engineering | |
CN102462561A (zh) | 一种sis软组织修复补片及其制备方法 | |
CN107397978B (zh) | 动物膀胱脱细胞基质的制备方法、所得的基质及应用 | |
CN202283366U (zh) | 一种sis软组织修复补片 | |
CN1903382A (zh) | 一种脱细胞基质异种骨的制作方法 | |
CN110433341A (zh) | 一种组织修复材料及其制备方法 | |
CN108114320A (zh) | 组织修复用补片、主体及制备方法 | |
CN105963787A (zh) | 新型生物补片的制备方法 | |
CN109675112B (zh) | 一种人源的脱细胞真皮基质的制备方法 | |
CN109529120A (zh) | 一种小肠黏膜下层基质修复凝胶的制备方法 | |
KR101269618B1 (ko) | 포유류의 연골조직에서 유래한 생체이식재 | |
CN110559485B (zh) | 一种生物组织基质材料及其制备方法与应用 | |
CN107029298A (zh) | 一种医用脱细胞真皮基质及其制备方法 | |
CN109550082A (zh) | 一种脱细胞基质凝胶的制备方法 | |
Kumar et al. | Extraction techniques for the decellularization of rat dermal constructs | |
CN103623464A (zh) | 一种自体颅骨回植技术的制备方法 | |
CN114848912B (zh) | 一种脱细胞真皮及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Taiwan high tech park of Songshan Lake high tech Industrial Development Zone of Dongguan City, Guangdong province 523808 Taoyuan Road No. 1, Dongguan Taiwan Biological Technology Cooperation Center 1 Building 1 room 05 Applicant after: Dongguan Bo and Regenerative Medicine Co.,Ltd. Address before: 710024 Shaanxi city of Xi'an Province South Second Ring Road, Yanta District Qinglong District Albert City building 11003 room 03 No. 1 vision Applicant before: SHAANXI BOYU REGENERATIVE MEDICINE Co.,Ltd. |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: Taiwan high tech park of Songshan Lake high tech Industrial Development Zone of Dongguan City, Guangdong province 523808 Taoyuan Road No. 1, Dongguan Taiwan Biological Technology Cooperation Center 1 Building 1 room 05 Patentee after: GUANGDONG BO YU REGENERATIVE MEDICINE CO.,LTD. Address before: Taiwan high tech park of Songshan Lake high tech Industrial Development Zone of Dongguan City, Guangdong province 523808 Taoyuan Road No. 1, Dongguan Taiwan Biological Technology Cooperation Center 1 Building 1 room 05 Patentee before: Dongguan Bo and Regenerative Medicine Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180123 |